Replies to post #130871 on NanoViricides Inc (NNVC)

[arvitar]

First NNVC has to come up with a lead candidate that shows promise for curing something. If they can't find a lead candidate, scale-up is a non-issue.

There have been an awful lot of PR's by Seymour claiming to have signed contracts with labs for exactly this purpose of identifying a lead, but every single announced study has so far gone POOF!

Fortunately for Seymour, investors have very short memories:


February 1, 2016 - NanoViricides Signs Agreement with the University of Wisconsin for Testing of Anti-Viral Candidates
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20the%20University%20of%20Wisconsin%20for%20Testing%20of%20Anti-Viral%20Candidates.html

February 11, 2016 - NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the University of Pittsburgh
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20for%20Ocular%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Herpes%20Keratitis%20with%20the%20University%20of%20Pittsburgh.html

February 16, 2016 - NanoViricides Signs Agreement for Ocular Testing of Its Drug Candidates for the Treatment of Herpes Keratitis with the Baylor College of Medicine
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20for%20Ocular%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Herpes%20Keratitis%20with%20the%20Baylor%20College%20of%20Medicine.html

May 31, 2016 - NanoViricides Signs Agreement with St. Jude Children's Research Hospital for further Influenza Drug Development
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20St%20Jude%20Childrens%20Research%20Hospital%20for%20further%20Influenza%20Drug%20Development.html

October 31, 2016 - NanoViricides Signs Agreement with SUNY Upstate Medical Center for Testing of Its Drug Candidates for the Treatment of Shingles
http://www.nanoviricides.com/press%20releases/2016/NanoViricides%20Signs%20Agreement%20with%20SUNY%20Upstate%20Medical%20Center%20for%20Testing%20of%20Its%20Drug%20Candidates%20for%20the%20Treatment%20of%20Shingles.html

[JG36]

Actually the best thing that could happen to us stockholders is if Big Pharma comes along and buys our shares for $4 each. Theracour is there solely to protect Dr. Diwan and to keep all intellectual property under his control even if NNVC goes bankrupt. There is no benefit whatsoever to other shareholders of making development cost 30% more than it should.